Titan Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TTNP and other ETFs, options, and stocks.

About TTNP

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.

CEO

Gim Shen Seow

CEOGim Shen Seow

Employees

Employees4

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

1992

Founded1992

Employees

Employees4

TTNP Key Statistics

Market cap

6.13M

Market cap6.13M

Price-Earnings ratio

-0.92

Price-Earnings ratio-0.92

Dividend yield

—

Dividend yield—

Average volume

3.17K

Average volume3.17K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$9.29

52 Week high$9.29

52 Week low

$0.25

52 Week low$0.25

Titan Pharmaceuticals

Why Robinhood?

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. Show more

TTNP Key Statistics

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.